PFDN1 and laryngotracheoesophageal cleft: However, PFDN1, 3, and 5 are not present in the Uri-complex, showing that the detected clinical effects in LC are mediated by canonical PFDN, likely mediated by its nuclear role acting on cyclin A expression, as proposed by Wang et al. [8].